PERSONIFICATED MEDICINE IN CLINICAL NEPHROLOGY

被引:0
作者
Mukhin, N. A. [1 ]
Fomin, V. V. [1 ]
机构
[1] IM Sechenov First Moscow Med Univ, Moscow, Russia
关键词
personification medicine; nephrology; chronic kidney disease; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; 9 GENE MYH9; AGALSIDASE-BETA THERAPY; FABRY-DISEASE; NEPHROTIC SYNDROME; AFRICAN-AMERICANS; PODOCIN MUTATIONS; GLOMERULOPATHY; POLYMORPHISMS; NEPHROPATHY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prospects of introduction of personification medicine principles into clinical nephrology are discussed with a special emphasis on prognosis of the course of chronic kidney diseases and response of the latter to pathogenetic therapy.
引用
收藏
页码:5 / 9
页数:5
相关论文
共 32 条
[1]  
[Anonymous], TER ARKH
[2]   Agalsidase-beta therapy for advanced Fabry disease - A randomized trial [J].
Banikazemi, Maryam ;
Bultas, Jan ;
Waldek, Stephen ;
Wilcox, William R. ;
Whitley, Chester B. ;
McDonald, Marie ;
Finkel, Richard ;
Packman, Seymour ;
Bichet, Daniel G. ;
Warnock, David G. ;
Desnick, Robert J. .
ANNALS OF INTERNAL MEDICINE, 2007, 146 (02) :77-86
[3]   A Novel WT1 Gene Mutation in a Three-Generation Family with Progressive Isolated Focal Segmental Glomerulosclerosis [J].
Benetti, Elisa ;
Caridi, Gianluca ;
Malaventura, Cristina ;
Dagnino, Monica ;
Leonardi, Emanuela ;
Artifoni, Lina ;
Ghiggeri, Gian Marco ;
Tosatto, Silvio C. E. ;
Murer, Luisa .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (04) :698-702
[4]   Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis [J].
Brown, Elizabeth J. ;
Schloendorff, Johannes S. ;
Becker, Daniel J. ;
Tsukaguchi, Hiroyasu ;
Uscinski, Andrea L. ;
Higgs, Henry N. ;
Henderson, Joel M. ;
Pollak, Martin R. .
NATURE GENETICS, 2010, 42 (01) :72-U91
[5]   NPHS2 (podocin) mutations in nephrotic syndrome. clinical spectrum and fine mechanisms [J].
Caridi, G ;
Perfumo, F ;
Ghiggeri, GM .
PEDIATRIC RESEARCH, 2005, 57 (05) :54R-61R
[6]   Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with the progression of IgA nephropathy in Chinese [J].
Cheng, Wenrong ;
Zhou, Xujie ;
Zhu, Li ;
Shi, Sufang ;
Lv, Jicheng ;
Liu, Lijun ;
Zhang, Hong .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (08) :2544-U1506
[7]  
Cohen CD, 2005, J NEPHROL, V18, P328
[8]   Fabry disease: Baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry [J].
Eng, C. M. ;
Fletcher, J. ;
Wilcox, W. R. ;
Waldek, S. ;
Scott, C. R. ;
Sillence, D. O. ;
Breunig, F. ;
Charrow, J. ;
Germain, D. P. ;
Nicholls, K. ;
Banikazemi, M. .
JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 (02) :184-192
[9]   Fabry disease: Guidelines for the evaluation and management of multi-organ system involvement [J].
Eng, Christine M. ;
Germain, Dominique P. ;
Banikazemi, Maryam ;
Warnock, David G. ;
Wanner, Christoph ;
Hopkin, Robert J. ;
Bultas, Jan ;
Lee, Philip ;
Sims, Katherine ;
Brodie, Scott E. ;
Pastores, Gregory M. ;
Strotmann, Joerg M. ;
Wilcox, William R. .
GENETICS IN MEDICINE, 2006, 8 (09) :539-548
[10]   Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN) [J].
Fogo, Agnes B. ;
Bostad, Leif ;
Svarstad, Einar ;
Cook, William J. ;
Moll, Solange ;
Barbey, Federic ;
Geldenhuys, Laurette ;
West, Michael ;
Ferluga, Dusan ;
Vujkovac, Bojan ;
Howie, Alexander J. ;
Burns, Aine ;
Reeve, Roy ;
Waldek, Stephen ;
Noel, Laure-Helene ;
Gruenfeld, Jean-Pierre ;
Valbuena, Carmen ;
Oliveira, Joao Paulo ;
Mueller, Justus ;
Breunig, Frank ;
Zhang, Xiao ;
Warnock, David G. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (07) :2168-2177